Moderna is a clinical stage biotechnology company creating medicines based on messenger RNA (mRNA) to improve the lives of patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Co.'s platform builds on basic and applied mRNA science, delivery technology, and manufacturing, providing it the capability to pursue in parallel a robust pipeline of new development candidates. Co. is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases.
MRNA — Key Stats (updated Friday, July 30, 10:38 AM)